↓ Skip to main content

In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation

Overview of attention for article published in Cellular Oncology (2211-3428), May 2013
Altmetric Badge

About this Attention Score

  • One of the highest-scoring outputs from this source (#10 of 153)
  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

patent
3 patents
facebook
2 Facebook pages

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
21 Mendeley
Title
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
Published in
Cellular Oncology (2211-3428), May 2013
DOI 10.1007/s13402-013-0134-8
Pubmed ID
Authors

Macarena Perán, Juan Antonio Marchal, Maria A. García, Julian Kenyon, David Tosh

Abstract

Previous research has suggested a putative utility of pancreatic (pro)enzymes in cancer treatment. The aim of the present study was to investigate the in vitro effects of a mixture of two pancreatic pro-enzymes, i.e., Chymotrypsinogen and Trypsinogen, and the enzyme Amylase on three human cancer cell lines, i.e., OE33 (derived from an oesophageal carcinoma), Panc1 (derived from a pancreatic carcinoma) and Caco-2 (derived from a colon carcinoma).

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 5%
Germany 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 33%
Student > Ph. D. Student 4 19%
Student > Master 3 14%
Unspecified 2 10%
Student > Bachelor 2 10%
Other 3 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 29%
Medicine and Dentistry 6 29%
Biochemistry, Genetics and Molecular Biology 4 19%
Unspecified 3 14%
Psychology 1 5%
Other 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2017.
All research outputs
#3,389,062
of 12,488,170 outputs
Outputs from Cellular Oncology (2211-3428)
#10
of 153 outputs
Outputs of similar age
#49,069
of 189,280 outputs
Outputs of similar age from Cellular Oncology (2211-3428)
#1
of 4 outputs
Altmetric has tracked 12,488,170 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 153 research outputs from this source. They receive a mean Attention Score of 2.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them